Kevin Davies is the founding editor of Bio-IT World and Nature Genetics, and the author of The $1,000 Genome (Free Press, 2010), an account of the revolution in DNA sequencing technologies, personal genomics, and personalized medicine. Kevin previously penned Cracking the Genome, the first published account of the race for the Human Genome Project and translated into 15 languages. His first book, co-authored with Michael White, was entitled Breakthrough, about the race to isolate the BRCA1 breast cancer gene. Born in London, Kevin read biochemistry at Oxford University and took a Ph.D in human genetics from St Mary’s Hospital Medical School (University of London). After postdoctoral fellowships at MIT and Harvard Medical School, he joined the editorial team of the journal Nature. In 1992, he was appointed editor of Nature’s first spin-off journal in 20 years, Nature Genetics. After stints at the Howard Hughes Medical Institute and editorial director of Cell Press, where he conceived and developed the journal Cancer Cell, in 2002 Davies was appointed the chief editor of Bio-IT World, a trade magazine covering the management of life sciences data. Launched by IDG, the publication is now owned and published by Cambridge Healthtech Institute. Kevin makes his home in Lexington, Massachusetts.